Related references
Note: Only part of the references are listed.Analysis of the transcriptional activity of endogenous NFAT5 in primary cells using transgenic NFAT-luciferase reporter mice
Beatriz Morancho et al.
BMC MOLECULAR BIOLOGY (2008)
A fluorimetric method for determination of calcineurin activity
Brian Roberts et al.
CELL CALCIUM (2008)
NFATc is required for TGFP-mediated transcriptional regulation of fibronectin
Scott L. Cobbs et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Loss of the α-isoform of calcineurin is sufficient to induce nephrotoxicity and altered expression of transforming growth factor-β
Jennifer L. Gooch et al.
TRANSPLANTATION (2007)
mTOR and cancer: insights into a complex relationship
David M. Sabatini
NATURE REVIEWS CANCER (2006)
An emerging role for calcineurin Aα in the development and function of the kidney
JL Gooch
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Involvement of calcineurin in transforming growth factor-β-mediated regulation of extracellular matrix accumulation
JL Gooch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy
BJ Wilkins et al.
CIRCULATION RESEARCH (2004)
Calcineurin A-α but not A-β is required for normal kidney development and function
JL Gooch et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Differential expression of calcineurin A isoforms in the diabetic kidney
JL Gooch et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Calcineurin is activated in diabetes and is required for glomerular hypertrophy and ECM accumulation
JL Gooch et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
Impaired cardiac hypertrophic response in calcineurin Aβ-deficient mice
OF Bueno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Insulin-like growth factor-I induces renal cell hypertrophy via a calcineurin-dependent mechanism
JL Gooch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo
LJ De Windt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Agiotensin II induced cardiac hypertrophy in vivo is inhibited by cyclosporin A in adult rats
PH Goldspink et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2001)
Calcineurin blockade prevents cardiac mitogen-activated protein kinase activation and hypertrophy in renovascular hypertension
A Murat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Transgenic overexpression of constitutively active protein kinase C ε causes concentric cardiac hypertrophy
Y Takeishi et al.
CIRCULATION RESEARCH (2000)
Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy
HW Lim et al.
CIRCULATION (2000)
Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition
HW Lim et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Smad proteins and transforming growth factor-beta signaling
M Schiffer et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
